Pontifax
Biotechnology · Venture Capital
56investments
22exits
$219.1Mraised by its portfolio in 12 months
77open roles in its portfolio
Overview
Pontifax is an Israeli venture capital firm focused on life sciences and healthcare innovation. It invests in biotechnology, pharmaceutical and medical technology companies in Israel, the United States and Europe, and it has also run dedicated agrifood technology funds. The firm was founded in 2004 by Tomer Kariv and Ran Nussbaum and is headquartered in Herzliya.
Investor profile
Venture capitalInvestments
56
15 of them startups
Hiring now
8
77 open roles
Rounds in 12 months
4
$219.1M raised
Exits
22
Focusshare of its companies
Health Care 83%Biotechnology 22%Sales & Marketing 9%Artificial Intelligence 4%Science & Engineering 4%Cybersecurity 4%Robotics 4%Consumer Electronics 4%
Where its companies are
United States 21%Israel 5%Belgium 2%Germany 2%
Stage of its companies
Series B 38%Series C and later 31%Series A 15%Pre-seed & seed 15%
Its companies, the freshest money firstAll 56 investments
AbcuroVenture round $39.4M · 3 mo ago
Fore BiotherapeuticsSeries D $67.4M · 4 mo ago
Climb BioVenture round $110.1M · 6 mo ago · 5 roles
MbodyVenture round $2.2M · 10 mo ago
ADCytherixSeries A $113.4M · 12 mo ago
OCON TherapeuticsVenture round $10M · 2 yr ago
Vanqua BioVenture round $45M · 2 yr ago
Lb PharmaceuticalsVenture round $110.7M · 3 yr ago · 1 role
Kite PharmaVenture round $100M · 3 yr ago · 47 roles
Antios TherapeuticsSeries B $75M · 5 yr ago
SoligenixVenture round $2M · 9 yr ago
Keros Therapeutics10 roles
Hiring fastestroles opened in 30 days
New in the portfolioadded to its portfolio page in 6 months
Co-investorscompanies they hold together
Similar investorstheir companies share markets and countries
Sources: its portfolio page, read Nov 3
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Herzliya
Israel
HQ
50-200 est. staff




OrbiMed
Kurma Partners
RA Capital Management
aMoon
Aisling Capital
V-Bio Ventures
Omega Funds
HealthCap
EcoR1 Capital
Novartis Venture Fund
Atlas Venture
Sofinnova Investments
venBio Partners
Foresite Capital